Visual Footcare Technologies

FDA-approved proprietary products; $5 B target market; Walgreens and Golden Living strategic partners; post revenues; endorsed by industry thought leaders

  • Stage $500K in TTM Revenue
  • Industry Healthcare Services
  • Location Trumbull, CT, US
  • Currency USD
  • Founded 2008
  • Employees 0

Company Summary

NeuroCords, Inc., an Israeli-based company that is developing a breakthrough NeuroGraphene technology which has demonstrated the promise to become the only effective cure for acute spinal cord injuries. Multiple in vivo and in vitro preclinical studies have demonstrated rapid recovery of neurophysiological sensory transmission in rats who have suffered acute spinal cord injuries or suffer from peripheral nerve injuries

Team

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free